PFIZER INC Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, before Tax
PFIZER INC (PFE) reported Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, before Tax of -$69.00 million for the 3-month period ending 2018-04-01, per its 10-Q filed 2018-05-10.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesBeforeTax · last filed 2018-05-10
- PFIZER INC other comprehensive income (loss), derivatives qualifying as hedges, before tax for the quarter ending 2018-04-01 was -$69.00M.
- PFIZER INC other comprehensive income (loss), derivatives qualifying as hedges, before tax for the quarter ending 2017-12-31 was $12.00M, a 98.29% decline year-over-year.
- PFIZER INC other comprehensive income (loss), derivatives qualifying as hedges, before tax for the quarter ending 2017-10-01 was $6.00M, a 75.00% decline year-over-year.
- PFIZER INC other comprehensive income (loss), derivatives qualifying as hedges, before tax for the quarter ending 2017-07-02 was -$297.00M.
- PFIZER INC other comprehensive income (loss), derivatives qualifying as hedges, before tax for fiscal 2017 was -$530.00M, a 5400.00% decline from fiscal 2016.
- PFIZER INC other comprehensive income (loss), derivatives qualifying as hedges, before tax for fiscal 2016 was $10.00M.
- PFIZER INC other comprehensive income (loss), derivatives qualifying as hedges, before tax for fiscal 2015 was -$165.00M, a 132.93% decline from fiscal 2014.
- PFIZER INC other comprehensive income (loss), derivatives qualifying as hedges, before tax for fiscal 2014 was $501.00M, a 27.16% increase from fiscal 2013.
| Period end | Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, before Tax 3 month | Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, before Tax 3 month as first filed | Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, before Tax 6 month | Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, before Tax 6 month as first filed | Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, before Tax 9 month | Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, before Tax 9 month as first filed | Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, before Tax 12 month | Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, before Tax 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2018-04-01 | -$69.00M 10-Q · filed 2018-05-10 | -$57.00M derived: sum of 2 quarters · filed 2018-05-10 | -$51.00M derived: sum of 3 quarters · filed 2018-05-10 | -$348.00M derived: sum of 4 quarters · filed 2018-05-10 | ||||
| 2017-12-31 | $12.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22 | $18.00M derived: sum of 2 quarters · filed 2018-02-22 | -$279.00M derived: sum of 3 quarters · filed 2018-02-22 | -$530.00M 10-K · filed 2018-02-22 | ||||
| 2017-10-01 | $6.00M 10-Q · filed 2017-11-09 | -$291.00M derived: sum of 2 quarters · filed 2017-11-09 | -$542.00M 10-Q · filed 2017-11-09 | $158.00M derived: sum of 4 quarters · filed 2018-05-10 | ||||
| 2017-07-02 | -$297.00M 10-Q · filed 2017-08-10 | -$548.00M 10-Q · filed 2017-08-10 | $152.00M derived: sum of 3 quarters · filed 2018-05-10 | $176.00M derived: sum of 4 quarters · filed 2018-05-10 | ||||
| 2017-04-02 | -$251.00M 10-Q · filed 2018-05-10 | $449.00M derived: sum of 2 quarters · filed 2018-05-10 | $473.00M derived: sum of 3 quarters · filed 2018-05-10 | $371.00M derived: sum of 4 quarters · filed 2018-05-10 | ||||
| 2016-12-31 | $700.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22 | $724.00M derived: sum of 2 quarters · filed 2018-02-22 | $622.00M derived: sum of 3 quarters · filed 2018-02-22 | $10.00M 10-K · filed 2018-02-22 | ||||
| 2016-10-02 | $24.00M 10-Q · filed 2017-11-09 | -$78.00M derived: sum of 2 quarters · filed 2017-11-09 | -$690.00M 10-Q · filed 2017-11-09 | -$230.00M derived: sum of 4 quarters · filed 2018-02-22 | ||||
| 2016-07-03 | -$102.00M 10-Q · filed 2017-08-10 | -$714.00M 10-Q · filed 2017-08-10 | -$254.00M derived: sum of 3 quarters · filed 2018-02-22 | -$505.00M derived: sum of 4 quarters · filed 2018-02-22 | ||||
| 2016-04-03 | -$612.00M 10-Q · filed 2017-05-11 | -$152.00M derived: sum of 2 quarters · filed 2018-02-22 | -$403.00M derived: sum of 3 quarters · filed 2018-02-22 | -$694.00M derived: sum of 4 quarters · filed 2018-02-22 | ||||
| 2015-12-31 | $460.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22 | $209.00M derived: sum of 2 quarters · filed 2018-02-22 | -$82.00M derived: sum of 3 quarters · filed 2018-02-22 | -$165.00M 10-K · filed 2018-02-22 | ||||
| 2015-09-27 | -$251.00M 10-Q · filed 2016-11-10 | -$542.00M derived: sum of 2 quarters · filed 2016-11-10 | -$625.00M 10-Q · filed 2016-11-10 | -$421.00M derived: sum of 4 quarters · filed 2017-02-23 | ||||
| 2015-06-28 | -$291.00M 10-Q · filed 2016-08-11 | -$373.00M 10-Q · filed 2016-08-11 | -$170.00M derived: sum of 3 quarters · filed 2017-02-23 | $99.00M derived: sum of 4 quarters · filed 2017-02-23 | ||||
| 2015-03-29 | -$82.00M 10-Q · filed 2016-05-12 | $121.00M derived: sum of 2 quarters · filed 2017-02-23 | $390.00M derived: sum of 3 quarters · filed 2017-02-23 | $465.00M derived: sum of 4 quarters · filed 2017-02-23 | ||||
| 2014-12-31 | $203.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $472.00M derived: sum of 2 quarters · filed 2017-02-23 | $547.00M derived: sum of 3 quarters · filed 2017-02-23 | $501.00M 10-K · filed 2017-02-23 | ||||
| 2014-09-28 | $269.00M 10-Q · filed 2015-11-05 | $344.00M derived: sum of 2 quarters · filed 2015-11-05 | $298.00M 10-Q · filed 2015-11-05 | $586.00M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-06-29 | $75.00M 10-Q · filed 2015-08-06 | $29.00M 10-Q · filed 2015-08-06 | $317.00M derived: sum of 3 quarters · filed 2016-02-29 | -$12.00M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-03-30 | -$46.00M 10-Q · filed 2015-05-07 | $242.00M derived: sum of 2 quarters · filed 2016-02-29 | -$87.00M derived: sum of 3 quarters · filed 2016-02-29 | $218.00M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2013-12-31 | $288.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | -$41.00M derived: sum of 2 quarters · filed 2016-02-29 | $264.00M derived: sum of 3 quarters · filed 2016-02-29 | $394.00M 10-K · filed 2016-02-29 | ||||
| 2013-09-29 | -$329.00M 10-Q · filed 2014-11-06 | $177.00M 10-Q · filed 2013-11-08 | -$24.00M derived: sum of 2 quarters · filed 2014-11-06 | $106.00M 10-Q · filed 2014-11-06 | $272.00M 10-Q · filed 2013-11-08 | $87.00M derived: sum of 4 quarters · filed 2015-02-27 | ||
| 2013-06-30 | $305.00M 10-Q · filed 2014-08-07 | $131.00M 10-Q · filed 2013-08-09 | $435.00M 10-Q · filed 2014-08-07 | $95.00M 10-Q · filed 2013-08-09 | $416.00M derived: sum of 3 quarters · filed 2015-02-27 | $650.00M derived: sum of 4 quarters · filed 2015-02-27 | ||
| 2013-03-31 | $130.00M 10-Q · filed 2014-05-08 | -$36.00M 10-Q · filed 2013-05-10 | $111.00M derived: sum of 2 quarters · filed 2015-02-27 | $345.00M derived: sum of 3 quarters · filed 2015-02-27 | $115.00M derived: sum of 4 quarters · filed 2015-02-27 | |||
| 2012-12-31 | -$19.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $215.00M derived: sum of 2 quarters · filed 2015-02-27 | -$15.00M derived: sum of 3 quarters · filed 2015-02-27 | $129.00M 10-K · filed 2015-02-27 | $421.00M 10-K · filed 2013-02-28 | |||
| 2012-09-30 | $234.00M 10-Q · filed 2013-11-08 | $225.00M 10-Q · filed 2012-11-09 | $4.00M derived: sum of 2 quarters · filed 2013-11-08 | $148.00M 10-Q · filed 2013-11-08 | $122.00M 10-Q · filed 2012-11-09 | $539.00M derived: sum of 4 quarters · filed 2014-02-28 | ||
| 2012-07-01 | -$230.00M 10-Q · filed 2013-08-09 | -$103.00M 10-Q · filed 2013-08-09 | $305.00M derived: sum of 3 quarters · filed 2014-02-28 | -$93.00M derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2012-04-01 | $127.00M 10-Q · filed 2013-05-10 | $535.00M derived: sum of 2 quarters · filed 2014-02-28 | $137.00M derived: sum of 3 quarters · filed 2014-02-28 | $141.00M derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2011-12-31 | $408.00M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $10.00M derived: sum of 2 quarters · filed 2014-02-28 | $14.00M derived: sum of 3 quarters · filed 2014-02-28 | -$189.00M 10-K · filed 2014-02-28 | -$263.00M 10-K · filed 2013-02-28 | |||
| 2011-10-02 | -$398.00M 10-Q · filed 2012-11-09 | -$394.00M derived: sum of 2 quarters · filed 2012-11-09 | -$597.00M 10-Q · filed 2012-11-09 | |||||
| 2011-07-03 | $4.00M 10-Q · filed 2012-08-09 | -$199.00M 10-Q · filed 2012-08-09 | ||||||
| 2010-12-31 | -$341.00M 10-K · filed 2013-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |